Skip to content

Clinical trials

Hyperlipoproteinemia Type II trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hyperlipoproteinemia Type II Country / region: Germany Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20091
20121
20151
20161
20172
20182
20191
20221
20232
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Recruiting3
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals4
Fresenius Medical Care Deutschland GmbH2
Merck Sharp & Dohme LLC2
Amgen1
CENTOGENE GmbH Rostock1
GWT-TUD GmbH1
Genzyme, a Sanofi Company1
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.1
The Medicines Company1
University of Ljubljana, Faculty of Medicine1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hyperlipoproteinemia Type II15
Hypercholesterolemia5
Dyslipidemias4
Cardiovascular Diseases3
Homozygous Familial Hypercholesterolemia3
Aortic Valve Stenosis2
Atherosclerosis2
Heart Failure2
Hyperlipidemias2
Arcus Senilis1

Trials

Showing 26 to 15 of 15. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.